| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2006-04-017681 |
| P8608 | Fatcat ID | release_ti3cf5rqkfhwfoiamam76tgb5m |
| P698 | PubMed publication ID | 16954502 |
| P5875 | ResearchGate publication ID | 6834815 |
| P50 | author | Tomohiro Morio | Q56635449 |
| Naoki Yamamoto | Q86902511 | ||
| P2093 | author name string | Satoru Watanabe | |
| Mamoru Ito | |||
| Mitsuo Honda | |||
| Shigeo Horibata | |||
| M Zahidunnabi Dewan | |||
| Zhong Yu | |||
| Kazuo Terashima | |||
| Norio Shimizu | |||
| Misako Yajima | |||
| Shinrai Ohta | |||
| Yoko Shiozawa | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 212-218 | |
| P577 | publication date | 2006-09-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses | |
| P478 | volume | 109 |
| Q36601933 | A Simple Mouse Model for the Study of Human Immunodeficiency Virus |
| Q43939988 | A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses |
| Q28478394 | A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice |
| Q34295935 | An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses |
| Q30423656 | Animal models for HIV/AIDS research |
| Q34267776 | Animal models for viral infection and cell exhaustion |
| Q37036786 | Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model |
| Q36528798 | Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model |
| Q34506515 | Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice |
| Q38912920 | Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice |
| Q34433569 | CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. |
| Q37195155 | Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders? |
| Q33382126 | Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients |
| Q84040857 | Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice |
| Q34501933 | Creation of "humanized" mice to study human immunity |
| Q50051618 | Creation of a long-acting nanoformulated dolutegravir |
| Q33577361 | Current advances in humanized mouse models |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q21142740 | Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice |
| Q33395882 | Dengue virus tropism in humanized mice recapitulates human dengue fever |
| Q87056737 | Development of human B cells and antibodies following human hematopoietic stem cell transplantation to Rag2(-/-)γc(-/-) mice |
| Q39432795 | Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. |
| Q34480264 | Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ. |
| Q51960368 | Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells. |
| Q39549994 | Effect of transcription peptide inhibitors on HIV-1 replication |
| Q34374708 | Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1. |
| Q36207395 | Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice |
| Q56898421 | Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells |
| Q44443580 | Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice |
| Q34058760 | Epstein-Barr virus induces erosive arthritis in humanized mice |
| Q37147232 | Establishing humanized mice using stem cells: maximizing the potential |
| Q29615069 | Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases |
| Q50420946 | Establishment of Immunodeficient Retinal Degeneration Model Mice and Functional Maturation of Human ESC-Derived Retinal Sheets after Transplantation. |
| Q45879357 | Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model |
| Q33676640 | Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model |
| Q36270576 | Forced expression of human macrophage colony-stimulating factor in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro. |
| Q38572329 | Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis |
| Q47582951 | Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice |
| Q28477591 | Further improvements of the P. falciparum humanized mouse model |
| Q64104899 | HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice |
| Q30425520 | HIV-1 Vaccine Trials: Evolving Concepts and Designs |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q38905274 | HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model |
| Q35750948 | HIV-1 infection and pathogenesis in a novel humanized mouse model |
| Q42989047 | High diversity of the immune repertoire in humanized NOD.SCID.gamma c-/- mice |
| Q34100221 | Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice |
| Q34124290 | Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo |
| Q35784905 | Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. |
| Q92327815 | Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors |
| Q28756080 | Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis |
| Q33939330 | Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes |
| Q36756422 | Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year |
| Q34607151 | Humanized mice in translational biomedical research |
| Q28728527 | Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1 |
| Q24658429 | Humanized mice show clinical signs of dengue fever according to infecting virus genotype |
| Q39329450 | Humanized mice: A brief overview on their diverse applications in biomedical research. |
| Q40548525 | Humanized mouse as an appropriate model for accelerated global HIV research and vaccine development: current trend |
| Q37089865 | Humanized mouse models of HIV infection |
| Q34533579 | Humanized mouse models of epstein-barr virus infection and associated diseases |
| Q37034627 | Identification of potential drug targets using genomics and proteomics: a systems approach |
| Q92376487 | Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia |
| Q42427922 | In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice |
| Q36651190 | Increasing hematopoietic stem cell yield to develop mice with human immune systems |
| Q37247943 | Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice |
| Q33990484 | Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody |
| Q38263295 | Latest animal models for anti-HIV drug discovery |
| Q34733983 | Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition |
| Q55387154 | Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes. |
| Q34358241 | Links between Progressive HIV-1 Infection of Humanized Mice and Viral Neuropathogenesis |
| Q37625904 | Long term human reconstitution and immune aging in NOD-Rag (-)-γ chain (-) mice |
| Q34920166 | Mice with human immune system components as in vivo models for infections with human pathogens |
| Q33401149 | Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice |
| Q27486807 | Mouse models for the study of HCV infection and virus–host interactions |
| Q34590684 | Mouse models with human immunity and their application in biomedical research |
| Q37365361 | Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model |
| Q34975218 | Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice |
| Q26823568 | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all |
| Q35914370 | Multiple restrictions of human immunodeficiency virus type 1 in feline cells |
| Q27014786 | New generation humanized mice for virus research: comparative aspects and future prospects |
| Q37034635 | Nonprimate models of HIV-1 infection and pathogenesis |
| Q37084504 | Novel humanized murine models for HIV research |
| Q34058148 | Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells |
| Q45869813 | Optimal conditions for lentiviral transduction of engrafting human CD34+ cells |
| Q33784852 | Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model |
| Q35535242 | Practical murine hematopathology: a comparative review and implications for research |
| Q26862954 | Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice |
| Q36994667 | RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus |
| Q37566034 | RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside |
| Q47608472 | Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo |
| Q37600607 | Renaissance for mouse models of human hematopoiesis and immunobiology |
| Q37617205 | Reproduction of epstein-barr virus infection and pathogenesis in humanized mice |
| Q37911028 | Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion. |
| Q83226952 | Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection |
| Q35803957 | Rodent models for HIV-associated neurocognitive disorders. |
| Q38025392 | Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses |
| Q37304853 | Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice |
| Q35962036 | Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection |
| Q26849806 | Studies of retroviral infection in humanized mice |
| Q39852737 | Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages |
| Q36835091 | Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. |
| Q37900419 | The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models |
| Q35206268 | The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment |
| Q37346027 | The utilization of humanized mouse models for the study of human retroviral infections |
| Q45324459 | Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model |
| Q35783479 | Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection |
| Q45910300 | Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model. |
| Q36201405 | What we are learning on HTLV-1 pathogenesis from animal models |
Search more.